Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Impact of mental health on outcomes of patients with relapsed and/or refractory diffuse large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.

Hematology/oncology and stem cell therapy·2026
Same author

Diagnostic Utility and Clinical Implications of Inpatient Fecal Occult Blood Testing.

Southern medical journal·2026
Same author

Efficacy of bispecific T-cell engagers after CAR T-cell therapy failure in aggressive large B-cell lymphoma.

Current research in translational medicine·2026
Same author

HES3-dependent regulatory functions in development and fusion-positive rhabdomyosarcoma.

bioRxiv : the preprint server for biology·2026
Same author

Efficacy of hyperbaric oxygen treatment in veterans and service members with traumatic brain injury-a study protocol for a blinded three-stage group sequential randomized controlled trial.

Trials·2026
Same author

Defining the Role of Intravenous Iron in The Treatment of Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2026

相关实验视频

Updated: May 7, 2026

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.1K

在放射性瘤学中评估新疗法:它们比标准疗法好吗?

Heloisa P Soares1, Ambuj Kumar, Stephanie Daniels

  • 1H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa 33612, USA.

JAMA
|February 25, 2005
PubMed
概括
此摘要是机器生成的。

创新的治疗方法在瘤学随机对照试验 (RCT) 中没有比标准治疗更优越. 虽然研究人员往往更喜欢新的选择,但元分析显示,与创新相似的成功率和增加的死亡率,突出需要RCT完成以确定有效的干预措施.

更多相关视频

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

13.9K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K

相关实验视频

Last Updated: May 7, 2026

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.1K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

13.9K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K

科学领域:

  • 在瘤学瘤学.
  • 临床试验 临床试验
  • 基于证据的医学基于证据的医学.

背景情况:

  • 在瘤学中,创新治疗与标准治疗的比较有效性仍然不清楚.
  • 准确的评估需要考虑出版率,试验质量和随机对照试验 (RCT) 中的比较者选择.

研究的目的:

  • 评估创新的癌症治疗方法的成功率.
  • 评估研究人员对实验与标准治疗的偏好.
  • 在RCT中确定创新治疗的统计学意义和元分析结果.

主要方法:

  • 从1968年至2002年期间,所有完成的放射治疗瘤学组 (RTOG) 的第三阶段随机对照试验 (RCT) 的分析.
  • 提取有关出版状况,方法质量和治疗比较的数据.
  • 进行元分析,比较创新治疗与标准治疗之间的生存率和死亡率.

主要成果:

  • 观察到高出版率 (95%) 和良好的试验质量.
  • 在71%的比较中,研究人员偏好支持标准治疗.
  • 分析显示,创新药物在生存方面并不比标准治疗更成功 (OR,1.01),但与治疗相关死亡率的增加有关 (OR,1.76).

结论:

  • 在瘤学中没有确定治疗成功的可预测模式;结果各不相同,创新疗法没有一致的优势.
  • 随机对照试验 (RCT) 系统的完整性得到了支持,因为只有在试验后才能可靠地确定成功的干预措施.
  • 需要进一步的研究,以了解影响治疗成功的因素,并优化患者的治疗结果.